Distance and affinity dependence of triplex-induced recombination.
Triplex-forming oligonucleotides (TFOs) have the potential to serve as gene therapeutic agents on the basis of their ability to mediate site-specific genome modification via induced recombination. However, high-affinity triplex formation is limited to polypurine/polypyrimidine sites in duplex DNA. Because of this sequence restriction, careful analysis is needed to identify suitable TFO target sites within or near genes of interest. We report here an examination of two key parameters which influence the efficiency of TFO-induced recombination: (1) binding affinity of the TFO for the target site and (2) the distance between the target site and the mutation to be corrected. To test the influence of binding affinity, we compared induced recombination in human cell-free extracts by a series of G-rich oligonucleotides with an identical base composition and an increasing number of mismatches in the third strand binding code. As the number of mismatches increased and, therefore, binding affinity decreased, induced recombination frequency also dropped. There was an apparent threshold at an equilibrium dissociation constant (K(d)) of 1 x 10(-)(7) M. In addition, TFO chemical modification with N,N-diethylethylenediamine (DEED) internucleoside linkages to confer improved binding was found to yield increased levels of induced recombination. To test the ability of triplex formation to induce recombination at a distance, episomal targets with informative reporter genes were constructed to contain polypurine TFO target sites at varying distances from the mutations to be corrected. TFO-induced recombination in mammalian cells between a plasmid vector and a donor oligonucleotide was detected at distances ranging from 24 to 750 bp. Together, these results indicate that TFO-induced recombination requires high-affinity binding but can affect sites hundreds of base pairs away from the position of triplex formation.
Knauert
Melissa P
MP
Department of Therapeutic Radiology, Yale University School of Medicine, P.O. Box 208040, New Haven, Connecticut 06520, USA.
Lloyd
Janice A
JA
Rogers
Faye A
FA
Datta
Hirock J
HJ
Bennett
Michael L
ML
Weeks
Daniel L
DL
Glazer
Peter M
PM
D000818:Animals; D020137:Base Pair Mismatch / Q000235:genetics; D001665:Binding Sites; D016466:CHO Cells; D019556:COS Cells; D002522:Chlorocebus aethiops; D006224:Cricetinae; D004247:DNA / Q000138:chemical synthesis / Q000235:genetics* / Q000378:metabolism*; D004260:DNA Repair / Q000235:genetics; D024202:Electrophoretic Mobility Shift Assay; D005029:Ethylenediamines / Q000737:chemistry; D005822:Genetic Vectors; D006147:Guanine / Q000378:metabolism; D006367:HeLa Cells; D006801:Humans; D009690:Nucleic Acid Conformation; D009692:Nucleic Acid Heteroduplexes / Q000138:chemical synthesis / Q000235:genetics / Q000378:metabolism; D009841:Oligonucleotides / Q000138:chemical synthesis / Q000378:metabolism; D011995:Recombination, Genetic; D014162:Transfection
D005029:Ethylenediamines; D009692:Nucleic Acid Heteroduplexes; D009841:Oligonucleotides; C051802:triplex DNA; D006147:Guanine; C477544:N,N-diethylethylenediamine; D004247:DNA